Lung Cancer Non-Small Cell Cancer (NSCLC) Clinical Trials

10 clinical trials for Lung Cancer Non-Small Cell Cancer (NSCLC) across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC — RECRUITING · PHASE2
• EGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC — RECRUITING · PHASE2
• Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC — RECRUITING · PHASE2
• Cross-sectorial Rehabilitation of Patients with Lung Cancer — RECRUITING · NA
• A Lay Navigation Intervention for Patients With Lung Cancer — NOT_YET_RECRUITING · NA
• Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors — OTHER
• Real-World Immuno-Radiotherapy for Advanced NSCLC — COMPLETED
• Pulmonary Interstitial Lymphography in Early Stage Lung Cancer — TERMINATED · NA
• Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors — TERMINATED
• Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors — TERMINATED

Refine this search